// App-Quantinova.ai

: Personalized risk stratification for patients with early prostate cancer (PRONTO): A Canadian team biomarker project.

Researchers

Presenter

  • David Monty Berman

Principal Investigators

  • Anna YW Lee

  • Palak Patel

  • Tamara Jamaspishvili

  • Walead Ebrahimizadeh

  • John Okello

  • Shaghayegh Rouzbeh

  • Nadia Boufaied

  • Laura A Lee

  • Simone Chevalier

  • Fadi Brimo

  • Vasundara Venkateswaran

  • Paul C Park

  • Ralph Buttyan

  • Axel A Thomson

  • Jacques Lapointe

  • Paul Christopher Boutros

  • John Bartlett

Medical Centers

  • Queen's University, Kingston, ON, CA

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Montreal University, Montreal, QC, Canada

  • McGill University Health Centre Reproductive Center, Montreal, QC, Canada

  • McGill University Health Centre, Montreal, QC, Canada

  • Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved